Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    FANCONI ANEMIA, COMPLEMENTATION GROUP I
Show Display Options
Download search resultsDownload the search results for:
FANCONI ANEMIA, COMPLEMENTATION GROUP I (1 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Unknown  Phase I Pilot Study of CD34 Enriched, Fanconi's Anemia Complementation Group C Gene Transduced Autologous Peripheral Blood Stem Cell Transplantation in Patients With Fanconi's Anemia
Condition: Fanconi's Anemia
Interventions: Drug: filgrastim;   Genetic: Autologous stem cells transduced with FACC retroviral vector;   Procedure: Autologous Stem Cell Transplantation

Indicates status has not been verified in more than two years